Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.19 USD | +11.38% | +16.03% | -4.96% |
May. 02 | NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue | MT |
May. 02 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.96% | 1.37B | |
+73.17% | 12.37B | |
-18.08% | 7.96B | |
+16.24% | 7.09B | |
+3.39% | 5.83B | |
+11.77% | 5.35B | |
+29.65% | 4.63B | |
-17.74% | 4B | |
-35.34% | 2.41B | |
+2.10% | 2B |
- Stock Market
- Equities
- NVCR Stock
- News NovoCure Limited
- Wedbush Upgrades NovoCure to Neutral From Underperform After Additional Details From LUNAR Study, Notes Limited Near-Term Catalysts; Lowers PT to $46 From $53